6.
Mathew E, Todorovic E, Truong T, Dickson B, Enepekides D, Poon I
. Metatypical Adenoid Cystic Carcinoma: A Variant Showing Prominent Squamous Differentiation With a Predilection for the Sinonasal Tract and Skull Base. Am J Surg Pathol. 2021; 46(6):816-822.
DOI: 10.1097/PAS.0000000000001850.
View
7.
Chiosea S, Miller M, Seethala R
. HRAS mutations in epithelial-myoepithelial carcinoma. Head Neck Pathol. 2013; 8(2):146-50.
PMC: 4022927.
DOI: 10.1007/s12105-013-0506-4.
View
8.
Sato M, Yamamoto H, Hatanaka Y, Nishijima T, Jiromaru R, Yasumatsu R
. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland. Pathol Res Pract. 2018; 214(4):586-592.
DOI: 10.1016/j.prp.2017.12.016.
View
9.
Nonaka T, Takei H
. Immunohistochemical Profile of Polymorphous Adenocarcinoma of Minor Salivary Gland: A Systematic Review and Meta-Analysis. Head Neck Pathol. 2022; 16(4):980-990.
PMC: 9729680.
DOI: 10.1007/s12105-022-01453-6.
View
10.
Persson M, Andersson M, Mitani Y, Brandwein-Weber M, Frierson Jr H, Moskaluk C
. Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional Study. Cancers (Basel). 2022; 14(15).
PMC: 9367430.
DOI: 10.3390/cancers14153691.
View
11.
Adkins B, Geromes A, Zhang L, Chernock R, Kimmelshue K, Lewis Jr J
. SOX10 and GATA3 in Adenoid Cystic Carcinoma and Polymorphous Adenocarcinoma. Head Neck Pathol. 2019; 14(2):406-411.
PMC: 7235140.
DOI: 10.1007/s12105-019-01046-w.
View
12.
Xu B, Chang K, Folpe A, Kao Y, Wey S, Huang H
. Head and Neck Mesenchymal Neoplasms With GLI1 Gene Alterations: A Pathologic Entity With Distinct Histologic Features and Potential for Distant Metastasis. Am J Surg Pathol. 2020; 44(6):729-737.
PMC: 7225037.
DOI: 10.1097/PAS.0000000000001439.
View
12.
Seethala R, Hunt J, Baloch Z, LiVolsi V, Barnes E
. Adenoid cystic carcinoma with high-grade transformation: a report of 11 cases and a review of the literature. Am J Surg Pathol. 2007; 31(11):1683-94.
DOI: 10.1097/PAS.0b013e3180dc928c.
View
13.
Martins C, Fonseca I, Roque L, Pereira T, Ribeiro C, Bullerdiek J
. PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry. Mod Pathol. 2005; 18(8):1048-55.
DOI: 10.1038/modpathol.3800386.
View
14.
Rotellini M, Palomba A, Baroni G, Franchi A
. Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors. Appl Immunohistochem Mol Morphol. 2013; 22(5):390-4.
DOI: 10.1097/PAI.0b013e3182936ea7.
View
15.
Brayer K, Frerich C, Kang H, Ness S
. Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma. Cancer Discov. 2015; 6(2):176-87.
PMC: 4744535.
DOI: 10.1158/2159-8290.CD-15-0859.
View
16.
Bishop J, Sajed D, Weinreb I, Dickson B, Bilodeau E, Agaimy A
. Microsecretory Adenocarcinoma of Salivary Glands: An Expanded Series of 24 Cases. Head Neck Pathol. 2021; 15(4):1192-1201.
PMC: 8633253.
DOI: 10.1007/s12105-021-01331-7.
View
17.
de Brito B, Giovanelli N, Egal E, Sanchez-Romero C, Nascimento J, Martins A
. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma. Hum Pathol. 2016; 57:152-159.
DOI: 10.1016/j.humpath.2016.07.011.
View
18.
El Hallani S, Udager A, Bell D, Fonseca I, Thompson L, Assaad A
. Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases. Am J Surg Pathol. 2017; 42(1):18-27.
PMC: 6530789.
DOI: 10.1097/PAS.0000000000000933.
View
19.
Kawahara A, Harada H, Abe H, Yamaguchi T, Taira T, Nakashima K
. Nuclear β-catenin expression in basal cell adenomas of salivary gland. J Oral Pathol Med. 2011; 40(6):460-6.
DOI: 10.1111/j.1600-0714.2011.01010.x.
View